Absolutely agree with everything except last sentence. I think shareholders saw dollar signs in their eyes and were hoping for that big pennyland prize, which rarely happens. Only time I've ever seen is if a small pharma actually gets Phase III FDA approval, then are bought out by Big Pharma. Don't recall seeing many others in pennyland make it big.
I think shareholders were hoping against hope that company was not a part of the problem. So not better scammers, just naive with rose-colored glasses.
Not sure of dates or anything else, but might be first time I recall seeing a federal judge giving shareholders a chance to make NSS case before revoking stock. Paper trails are very long when NSS exists and would be monumental task for shareholders to find a way to expose, but not impossible.
Totally agree with not going against hedge funds who are shorting. That is the big money and should be followed.
